Healthcare · Medical - Instruments & Supplies · Market cap $3.8B · $54.21 · 52-week range $12.56–$58.90
Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-09-01 | Teplitsky Liane Rae | officer: Chief Operating Officer | 1,001 | $49.95 | $50,000 | SEC Form 4 |
| 2026-08-31 | Teplitsky Liane Rae | officer: Chief Operating Officer | 1,024 | $48.80 | $49,971 | SEC Form 4 |
| 2026-08-28 | Teplitsky Liane Rae | officer: Chief Operating Officer | 1,034 | $48.35 | $49,994 | SEC Form 4 |
| 2026-08-26 | Teplitsky Liane Rae | officer: Chief Operating Officer | 1,036 | $48.23 | $49,971 | SEC Form 4 |
| 2026-05-11 | DUGGAN ROBERT W | director, 10 percent owner: | 660,233 | $19.69 | $12,999,988 | SEC Form 4 |
| 2026-05-11 | LAVIOLETTE PAUL A | director, officer: Chief Executive Officer | 15,000 | $19.69 | $295,350 | SEC Form 4 |
| 2026-05-11 | LAVIOLETTE PAUL A | director, officer: Chief Executive Officer | 15,000 | $19.69 | $295,350 | SEC Form 4 |
| 2026-05-11 | DUGGAN ROBERT W | director, 10 percent owner: | 660,233 | $19.69 | $12,999,988 | SEC Form 4 |
Last updated September 15, 2026.
ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.